A Phase 1 Multicenter Open-label Trial to Evaluate the Safety of Talimogene Laherparepvec Injected into Liver Tumors
B
Bert O'Neil, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to find out more about talimogene laherparepvec in people with liver tumors that cannot be removed by surgery.
Description
The purpose of this study is to find out more about talimogene laherparepvec in people with liver tumors that cannot be removed by surgery.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
liver tumor
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
20 Apr 2024.
Study ID: 1511871819
